메뉴 건너뛰기




Volumn 21, Issue 5, 2008, Pages 531-537

Prevention of amyloid β-induced memory impairment by fluvastatin, associated with the decrease in amyloid β accumulation and oxidative stress in amyloid β injection mouse model

Author keywords

Amyloid injection mouse model; Anti oxidative effect; Fluvastatin

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SIMVASTATIN; AMYLOID BETA PROTEIN; INDOLE DERIVATIVE; MONOUNSATURATED FATTY ACID;

EID: 46449138791     PISSN: 11073756     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijmm.21.5.531     Document Type: Article
Times cited : (42)

References (52)
  • 1
    • 0021256895 scopus 로고
    • Alzheimer's disease: Initial report of the purification and characterization of a novel cerebro-vascular amyloid protein
    • Glenner GG and Wong CW: Alzheimer's disease: initial report of the purification and characterization of a novel cerebro-vascular amyloid protein. Biochem Biophys Res Commun 120: 885-890, 1984.
    • (1984) Biochem Biophys Res Commun , vol.120 , pp. 885-890
    • Glenner, G.G.1    Wong, C.W.2
  • 2
    • 0026088977 scopus 로고
    • Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
    • Goate A, Chartier-Harlin MC, Mullan M, et al: Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349: 704-706, 1991.
    • (1991) Nature , vol.349 , pp. 704-706
    • Goate, A.1    Chartier-Harlin, M.C.2    Mullan, M.3
  • 3
    • 0025925236 scopus 로고
    • The 717Val - Ile substitution in amyloid precursor protein is associated with familial Alzheimer's disease regardless of ethnic groups
    • Yoshioka K, Miki T, Katsuya T, Ogihara T and Sakaki Y: The 717Val - Ile substitution in amyloid precursor protein is associated with familial Alzheimer's disease regardless of ethnic groups. Biochem Biophys Res Commun 178: 1141-1146, 1991.
    • (1991) Biochem Biophys Res Commun , vol.178 , pp. 1141-1146
    • Yoshioka, K.1    Miki, T.2    Katsuya, T.3    Ogihara, T.4    Sakaki, Y.5
  • 4
    • 0026907151 scopus 로고
    • A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid
    • Mullan M, Crawford F, Axelman K, Houlden H, Lilius L, Winblad B and Lannfelt L: A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Nat Genet 1: 345-347, 1992.
    • (1992) Nat Genet , vol.1 , pp. 345-347
    • Mullan, M.1    Crawford, F.2    Axelman, K.3    Houlden, H.4    Lilius, L.5    Winblad, B.6    Lannfelt, L.7
  • 5
    • 0029004341 scopus 로고
    • Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
    • Sherrington R, Rogaev EI, Liang Y, et al: Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375: 754-760, 1995.
    • (1995) Nature , vol.375 , pp. 754-760
    • Sherrington, R.1    Rogaev, E.I.2    Liang, Y.3
  • 6
    • 0029101491 scopus 로고
    • Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene
    • Rogaev EI, Sherrington R, Rogaeva EA, et al: Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376: 775-778, 1995.
    • (1995) Nature , vol.376 , pp. 775-778
    • Rogaev, E.I.1    Sherrington, R.2    Rogaeva, E.A.3
  • 7
    • 0029087026 scopus 로고
    • Candidate gene for the chromosome 1 familial Alzheimer's disease locus
    • Levy-Lahad E, Wasco W, Poorkaj P, et al: Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269: 973-977, 1995.
    • (1995) Science , vol.269 , pp. 973-977
    • Levy-Lahad, E.1    Wasco, W.2    Poorkaj, P.3
  • 8
    • 0028587336 scopus 로고
    • APP717 missense mutation affects the ratio of amyloid beta protein species (A beta 1-42/43 and A beta 1-40) in familial Alzheimer's disease brain
    • Tamaoka A, Odaka A, Ishibashi Y. et al: APP717 missense mutation affects the ratio of amyloid beta protein species (A beta 1-42/43 and A beta 1-40) in familial Alzheimer's disease brain. J Biol Chem 269: 32721-32724, 1994.
    • (1994) J Biol Chem , vol.269 , pp. 32721-32724
    • Tamaoka, A.1    Odaka, A.2    Ishibashi, Y.3
  • 9
    • 16944362157 scopus 로고    scopus 로고
    • Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice
    • Citron M, Westaway D, Xia W. et al: Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nat Med 3: 67-72, 1997.
    • (1997) Nat Med , vol.3 , pp. 67-72
    • Citron, M.1    Westaway, D.2    Xia, W.3
  • 10
    • 0028169925 scopus 로고
    • Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: Evidence that an initially deposited species is A beta 42(43)
    • Iwatsubo T, Odaka A, Suzuk Ni, Mizusawa H, Nukina N and Ihara Y: Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron 13: 45-53, 1994.
    • (1994) Neuron , vol.13 , pp. 45-53
    • Iwatsubo, T.1    Odaka, A.2    Ni, S.3    Mizusawa, H.4    Nukina, N.5    Ihara, Y.6
  • 11
    • 0038117796 scopus 로고    scopus 로고
    • Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline
    • Naslund J, Haroutunian V, Mohs R. Davis KL, Davies P, Greengard P and Buxbaum JD: Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. JAMA 283: 1571-1577, 2000.
    • (2000) JAMA , vol.283 , pp. 1571-1577
    • Naslund, J.1    Haroutunian, V.2    Mohs, R.3    Davis, K.L.4    Davies, P.5    Greengard, P.6    Buxbaum, J.D.7
  • 12
    • 0033772113 scopus 로고    scopus 로고
    • Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors
    • Wolozin B, Kellman W, Ruosseau P, Celesia GG and Siegel G: Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch Neurol 57: 1439-1443, 2000.
    • (2000) Arch Neurol , vol.57 , pp. 1439-1443
    • Wolozin, B.1    Kellman, W.2    Ruosseau, P.3    Celesia, G.G.4    Siegel, G.5
  • 14
    • 22144453835 scopus 로고    scopus 로고
    • Atorvastatin therapy lowers circulating cholesterol but not free radical activity in advance of identifiable clinical benefit in the treatment of mild-to-moderate AD
    • Sparks DL, Sabbagh MN, Connor DJ, et al: Atorvastatin therapy lowers circulating cholesterol but not free radical activity in advance of identifiable clinical benefit in the treatment of mild-to-moderate AD. Curr Alzheimer Res 2: 343-353, 2005.
    • (2005) Curr Alzheimer Res , vol.2 , pp. 343-353
    • Sparks, D.L.1    Sabbagh, M.N.2    Connor, D.J.3
  • 15
    • 33745739157 scopus 로고    scopus 로고
    • Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease: Results of the Alzheimer's Disease Cholesterol-Lowering Treatment (ADCLT) trial
    • Sparks DL, Connor DJ, Sabbagh MN, Petersen RB, Lopez J and Browne P: Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease: results of the Alzheimer's Disease Cholesterol-Lowering Treatment (ADCLT) trial. Acta Neurol Scand Suppl 185: 3-7, 2006.
    • (2006) Acta Neurol Scand , Issue.SUPPL. 185 , pp. 3-7
    • Sparks, D.L.1    Connor, D.J.2    Sabbagh, M.N.3    Petersen, R.B.4    Lopez, J.5    Browne, P.6
  • 16
    • 0001504829 scopus 로고    scopus 로고
    • Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo
    • Fassbender K, Simons M, Bergmann C, et al: Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. Proc Natl Acad Sci USA 98: 5856-5861, 2001.
    • (2001) Proc Natl Acad Sci USA , vol.98 , pp. 5856-5861
    • Fassbender, K.1    Simons, M.2    Bergmann, C.3
  • 17
    • 4143063543 scopus 로고    scopus 로고
    • Atorvastatin-induced activation of Alzheimer's alpha secretase is resistant to standard inhibitors of protein phosphorylation-regulated ectodomain shedding
    • Parvathy S, Ehrlich M, Pedrini S, et al: Atorvastatin-induced activation of Alzheimer's alpha secretase is resistant to standard inhibitors of protein phosphorylation-regulated ectodomain shedding. J Neurochem 90: 1005-1010, 2004.
    • (2004) J Neurochem , vol.90 , pp. 1005-1010
    • Parvathy, S.1    Ehrlich, M.2    Pedrini, S.3
  • 18
    • 33745109326 scopus 로고    scopus 로고
    • High-dose statin treatment does not alter plasma marker for brain cholesterol metabolism in patients with moderately elevated plasma cholesterol levels
    • Thelen KM, Laaksonen R, Paiva H, Lehtimaki T and Lutjohann D: High-dose statin treatment does not alter plasma marker for brain cholesterol metabolism in patients with moderately elevated plasma cholesterol levels. J Clin Pharmacol 46: 812-816, 2006.
    • (2006) J Clin Pharmacol , vol.46 , pp. 812-816
    • Thelen, K.M.1    Laaksonen, R.2    Paiva, H.3    Lehtimaki, T.4    Lutjohann, D.5
  • 19
    • 2442489033 scopus 로고    scopus 로고
    • Relation of plasma lipids to Alzheimer disease and vascular dementia
    • Reitz C, Tang MX, Luchsinger J and Mayeux R: Relation of plasma lipids to Alzheimer disease and vascular dementia. Arch Neurol 61: 705-714, 2004.
    • (2004) Arch Neurol , vol.61 , pp. 705-714
    • Reitz, C.1    Tang, M.X.2    Luchsinger, J.3    Mayeux, R.4
  • 20
    • 0032836539 scopus 로고    scopus 로고
    • Long-term deprivation of oestrogens by ovariectomy potentiates beta-amyloid-induced working memory deficits in rats
    • Yamada K, Tanaka T, Zou LB, et al: Long-term deprivation of oestrogens by ovariectomy potentiates beta-amyloid-induced working memory deficits in rats. Br J Pharmacol 128: 419-427, 1999.
    • (1999) Br J Pharmacol , vol.128 , pp. 419-427
    • Yamada, K.1    Tanaka, T.2    Zou, L.B.3
  • 21
    • 0028177692 scopus 로고
    • β-amyloid protein-induced Alzheimer's disease animal model
    • Nitta A, Itoh A, Hasegawa T and Nabeshima T: β-amyloid protein-induced Alzheimer's disease animal model. Neurosci Lett 170: 63-66, 1994.
    • (1994) Neurosci Lett , vol.170 , pp. 63-66
    • Nitta, A.1    Itoh, A.2    Hasegawa, T.3    Nabeshima, T.4
  • 22
    • 20144387217 scopus 로고    scopus 로고
    • A humanin derivative, S14G-HN, prevents amyloid-beta-induced memory impairment in mice
    • Tajima H, Kawasumi M, Chiba T, et al: A humanin derivative, S14G-HN, prevents amyloid-beta-induced memory impairment in mice. J Neurosci Res 79: 714-723, 2005.
    • (2005) J Neurosci Res , vol.79 , pp. 714-723
    • Tajima, H.1    Kawasumi, M.2    Chiba, T.3
  • 23
    • 0034521392 scopus 로고    scopus 로고
    • Clearance of Alzheimer's amyloid-β(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier
    • Shibata M, Yamada S, Kumar SR, et al: Clearance of Alzheimer's amyloid-β(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest 106: 1489-1499, 2000.
    • (2000) J Clin Invest , vol.106 , pp. 1489-1499
    • Shibata, M.1    Yamada, S.2    Kumar, S.R.3
  • 24
    • 0033433983 scopus 로고    scopus 로고
    • The role of nociceptin in cognition
    • Nabeshima T, Noda Y and Mamiya T: The role of nociceptin in cognition. Brain Res 848: 167-173, 1999.
    • (1999) Brain Res , vol.848 , pp. 167-173
    • Nabeshima, T.1    Noda, Y.2    Mamiya, T.3
  • 25
    • 0036924890 scopus 로고    scopus 로고
    • Deficiency of glutathione peroxidase-1 sensitizes hyperhomocysteinemic mice to endothelial dysfunction
    • Dayal S, Brown KL, Weydert CJ, et al: Deficiency of glutathione peroxidase-1 sensitizes hyperhomocysteinemic mice to endothelial dysfunction. Arterioscler Thromb Vase Biol 22: 1996-2002, 2002.
    • (2002) Arterioscler Thromb Vase Biol , vol.22 , pp. 1996-2002
    • Dayal, S.1    Brown, K.L.2    Weydert, C.J.3
  • 26
    • 0141621234 scopus 로고    scopus 로고
    • Kinetics of amyloid beta-protein degradation determined by novel fluorescence- and fluorescence polarization-based assays
    • Leissring MA, Lu A, Condron MM, Teplow DB, Stein RL, Farris W and Selkoe DJ: Kinetics of amyloid beta-protein degradation determined by novel fluorescence- and fluorescence polarization-based assays. J Biol Chem 278: 37314-37320, 2003.
    • (2003) J Biol Chem , vol.278 , pp. 37314-37320
    • Leissring, M.A.1    Lu, A.2    Condron, M.M.3    Teplow, D.B.4    Stein, R.L.5    Farris, W.6    Selkoe, D.J.7
  • 27
    • 0021137049 scopus 로고
    • A highly sensitive fluorometric assay for 'enkephalinase', a neutral metalloendopeptidase that releases tyrosine-glycine-glycine from enkephalins
    • Florentin D, Sassi A and Roques BP: A highly sensitive fluorometric assay for 'enkephalinase', a neutral metalloendopeptidase that releases tyrosine-glycine-glycine from enkephalins. Anal Biochem 141: 62-69, 1984.
    • (1984) Anal Biochem , vol.141 , pp. 62-69
    • Florentin, D.1    Sassi, A.2    Roques, B.P.3
  • 28
    • 0033621739 scopus 로고    scopus 로고
    • Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: Suppression leads to biochemical and pathological deposition
    • Iwata N, Tsubuki S, Takaki Y, et al: Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nat Med 6: 143-150, 2000.
    • (2000) Nat Med , vol.6 , pp. 143-150
    • Iwata, N.1    Tsubuki, S.2    Takaki, Y.3
  • 29
    • 0346101885 scopus 로고    scopus 로고
    • Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death
    • Leissring MA, Farris W, Chang AY, et al: Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death. Neuron 40: 1087-1093, 2003.
    • (2003) Neuron , vol.40 , pp. 1087-1093
    • Leissring, M.A.1    Farris, W.2    Chang, A.Y.3
  • 30
    • 0000398342 scopus 로고    scopus 로고
    • Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation
    • Qiu WQ, Walsh DM, Ye Z, et al: Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation. J Biol Chem 273: 32730-32738, 1998.
    • (1998) J Biol Chem , vol.273 , pp. 32730-32738
    • Qiu, W.Q.1    Walsh, D.M.2    Ye, Z.3
  • 31
    • 0034161516 scopus 로고    scopus 로고
    • Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme
    • Vekrellis K, Ye Z, Qiu WQ, et al: Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme. J Neurosci 20: 1657-1665, 2000.
    • (2000) J Neurosci , vol.20 , pp. 1657-1665
    • Vekrellis, K.1    Ye, Z.2    Qiu, W.Q.3
  • 32
    • 0036226252 scopus 로고    scopus 로고
    • Melatonin blocks rat hippocampal neuronal apoptosis induced by amyloid beta-peptide 25-35
    • Shen YX, Xu SY, Wei W, Wang, XL Wang H and Sun X: Melatonin blocks rat hippocampal neuronal apoptosis induced by amyloid beta-peptide 25-35. J Pineal Res 32: 163-167, 2002.
    • (2002) J Pineal Res , vol.32 , pp. 163-167
    • Shen, Y.X.1    Xu, S.Y.2    Wei, W.3    Wang, X.L.4    Wang, H.5    Sun, X.6
  • 33
    • 1842738222 scopus 로고    scopus 로고
    • Kinetics of the neuroinflammation-oxidative stress correlation in rat brain following the injection of fibrillar amyloid-beta onto the hippocampus in vivo
    • Rosales-Corral S, Tan DX, Reiter RJ, Valdivia-Velazquez M, Acosta-Martinez JP and Ortiz GG: Kinetics of the neuroinflammation-oxidative stress correlation in rat brain following the injection of fibrillar amyloid-beta onto the hippocampus in vivo. J Neuroimmunol 150: 20-28, 2004.
    • (2004) J Neuroimmunol , vol.150 , pp. 20-28
    • Rosales-Corral, S.1    Tan, D.X.2    Reiter, R.J.3    Valdivia-Velazquez, M.4    Acosta-Martinez, J.P.5    Ortiz, G.G.6
  • 34
    • 0036449696 scopus 로고    scopus 로고
    • Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels as a central target for the development of human AD and AD-like pathology in aged transgenic mice
    • Aliev G, Seyidova D, Neal ML, et al: Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels as a central target for the development of human AD and AD-like pathology in aged transgenic mice. Ann NY Acad Sci 977: 45-64, 2002.
    • (2002) Ann NY Acad Sci , vol.977 , pp. 45-64
    • Aliev, G.1    Seyidova, D.2    Neal, M.L.3
  • 35
    • 0036468599 scopus 로고    scopus 로고
    • Fluvastatin reduces modification of low-density lipoprotein in hyperlipidemic rabbit loaded with oxidative stress
    • Yamaguchi Y, Matsuno S, Kagota S, Haginaka J and Kunitomo M: Fluvastatin reduces modification of low-density lipoprotein in hyperlipidemic rabbit loaded with oxidative stress. Eur J Pharmacol 436: 97-105, 2002.
    • (2002) Eur J Pharmacol , vol.436 , pp. 97-105
    • Yamaguchi, Y.1    Matsuno, S.2    Kagota, S.3    Haginaka, J.4    Kunitomo, M.5
  • 36
    • 7244224783 scopus 로고    scopus 로고
    • Fluvastatin enhances the inhibitory effects of a selective AT1 receptor blocker, valsartan, on atherosclerosis
    • Li Z, Iwai M, Wu L, et al: Fluvastatin enhances the inhibitory effects of a selective AT1 receptor blocker, valsartan, on atherosclerosis. Hypertension 44: 758-763, 2004.
    • (2004) Hypertension , vol.44 , pp. 758-763
    • Li, Z.1    Iwai, M.2    Wu, L.3
  • 37
    • 33751398964 scopus 로고    scopus 로고
    • Early administration of fluvastatin, but not at the onset of ischemia or reperfusion, attenuates myocardial ischemia-reperfusion injury through the nitric oxide pathway rather than its antioxidant property
    • Matsuki A, Igawa A, Nozawa T, Nakadate T, Igarashi N, Nonomura M and Inoue H: Early administration of fluvastatin, but not at the onset of ischemia or reperfusion, attenuates myocardial ischemia-reperfusion injury through the nitric oxide pathway rather than its antioxidant property. Circ J 70: 1643-1649, 2006.
    • (2006) Circ J , vol.70 , pp. 1643-1649
    • Matsuki, A.1    Igawa, A.2    Nozawa, T.3    Nakadate, T.4    Igarashi, N.5    Nonomura, M.6    Inoue, H.7
  • 38
    • 20844454775 scopus 로고    scopus 로고
    • Activation of ERK in renal fibrosis after unilateral ureteral obstruction: Modulation by antioxidants
    • Pat B, Yang T, Kong C, Watters D, Johnson DW and Gobe G: Activation of ERK in renal fibrosis after unilateral ureteral obstruction: modulation by antioxidants. Kidney Int 67: 931-943, 2005.
    • (2005) Kidney Int , vol.67 , pp. 931-943
    • Pat, B.1    Yang, T.2    Kong, C.3    Watters, D.4    Johnson, D.W.5    Gobe, G.6
  • 39
    • 0031904324 scopus 로고    scopus 로고
    • Abnormalities of neural circuitry in Alzheimer's disease: Hippocampus and cortical cholinergic innervation
    • Geula C: Abnormalities of neural circuitry in Alzheimer's disease: hippocampus and cortical cholinergic innervation. Neurology 51: S18-S29,1998.
    • (1998) Neurology , vol.51
    • Geula, C.1
  • 40
    • 8844285984 scopus 로고    scopus 로고
    • Mouse models of Alzheimer's disease: Insight into treatment
    • German DC and Eisch AJ: Mouse models of Alzheimer's disease: insight into treatment. Rev Neurosci 15: 353-369, 2004.
    • (2004) Rev Neurosci , vol.15 , pp. 353-369
    • German, D.C.1    Eisch, A.J.2
  • 41
    • 18144419392 scopus 로고    scopus 로고
    • APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: The Three-City Study
    • Dufouil C, Richard F, Fievet N, et al: APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study. Neurology 64: 1531-1538, 2005.
    • (2005) Neurology , vol.64 , pp. 1531-1538
    • Dufouil, C.1    Richard, F.2    Fievet, N.3
  • 42
    • 22844431778 scopus 로고    scopus 로고
    • Statin use and the risk of incident dementia: The Cardiovascular Health Study
    • Rea TD, Breitner JC, Psaty BM, et al: Statin use and the risk of incident dementia: the Cardiovascular Health Study. Arch Neurol 62: 1047-1051, 2005.
    • (2005) Arch Neurol , vol.62 , pp. 1047-1051
    • Rea, T.D.1    Breitner, J.C.2    Psaty, B.M.3
  • 46
    • 33750002577 scopus 로고    scopus 로고
    • Statins inhibit the dimerization of beta-secretase via both isoprenoid- and cholesterol-mediated mechanisms
    • Parsons RB, Price GC, Farrant JK, Subramaniam D, Adeagbo-Sheikh J and Austen BM: Statins inhibit the dimerization of beta-secretase via both isoprenoid- and cholesterol-mediated mechanisms. Biochem J 399: 205-214, 2006.
    • (2006) Biochem J , vol.399 , pp. 205-214
    • Parsons, R.B.1    Price, G.C.2    Farrant, J.K.3    Subramaniam, D.4    Adeagbo-Sheikh, J.5    Austen, B.M.6
  • 48
    • 0346736491 scopus 로고    scopus 로고
    • Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells
    • Hernandez-Perera O, Perez-Sala D, Navarro-Antolin J, Sanchez-Pascuala R, Hernandez G, Diaz C and Lamas S: Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells. J Clin Invest 101: 2711-2719, 1998.
    • (1998) J Clin Invest , vol.101 , pp. 2711-2719
    • Hernandez-Perera, O.1    Perez-Sala, D.2    Navarro-Antolin, J.3    Sanchez-Pascuala, R.4    Hernandez, G.5    Diaz, C.6    Lamas, S.7
  • 49
    • 0032555154 scopus 로고    scopus 로고
    • Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase
    • Endres M, Laufs U, Huang Z, Nakamura T, Huang P, Moskowitz MA and Liao JK: Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc Natl Acad Sci USA 95: 8880-8885, 1998.
    • (1998) Proc Natl Acad Sci USA , vol.95 , pp. 8880-8885
    • Endres, M.1    Laufs, U.2    Huang, Z.3    Nakamura, T.4    Huang, P.5    Moskowitz, M.A.6    Liao, J.K.7
  • 50
    • 0033048997 scopus 로고    scopus 로고
    • Attention and executive deficits in Alzheimer's disease. A critical review
    • Perry RJ and Hodges JR: Attention and executive deficits in Alzheimer's disease. A critical review. Brain 122: 383-404, 1999.
    • (1999) Brain , vol.122 , pp. 383-404
    • Perry, R.J.1    Hodges, J.R.2
  • 51
    • 0034125843 scopus 로고    scopus 로고
    • On neurodegenerative diseases, models, and treatment strategies: Lessons learned and lessons forgotten a generation following the cholinergic hypothesis
    • Bartus RT: On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis. Exp Neurol 163: 495-529, 2000.
    • (2000) Exp Neurol , vol.163 , pp. 495-529
    • Bartus, R.T.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.